Technologies Available for Licensing
HANTAVIRUS VACCINE
Vaccine formulations for inducing protective immune response to Hantaviruses in humans are disclosed. These formulations include an attenuated vaccinia virus vector containing cDNA's encoding Hantavirus nucleocapsid N protein, G1 and G2 glycoproteins. Methods for the use of these formulations also are disclosed.
Docket:RIID 87-04
Publication/Issued No.:5,614,193
Publication/Issue Date:1997-03-25
Categories: Vaccine
More Detail:Visit USPTO.GOV
Lab:RIID
Inventor(s):SCHMALJOHN, C.; MCCLAIN, D.; DALRYMPLE, J.
Abstract:Download